Plus Therapeutics


Plus Therapeutics (Nasdaq: PSTV) is a U.S. clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for rare and difficult-to-treat cancers.

Industries

Employees

11-50

Links


Org chart

Marc Hedrick
President & CEO
Collapse
Russ Havranek
VP, Corporate Strategy & New Product Planning
Russ H.
Vp, Corporate Strategy & New Product Planning
Daniel Ortega
Senior Director Drug Development And Production
Kara Quinlan Davis
Corporate Counsel

Board & advisors

Robert Lenk
Director
Manish Aghi
Clinical Advisor
Nicholas Butowski
Clinical Advisor
Russell Lonser
Clinical Advisor
Alireza Mohammadi
Clinical Advisor
Michael Vogelbaum
Clinical Advisor
Andrew Brenner
Scientific Advisor
John McKew
Scientific Advisor
Vladimir P. Torchilin
Scientific Advisor


Offices